On Jan. 11, 2023, Roche announced treatment of uncomplicated influenza and for post-exposure prophylaxis of influenza. Post-exposure prophylaxis…
On Jan. 11, 2023, the U.S. Food and Drug Administration reported that a single booster dose with an…
On Jan. 10, 2023, the WHO announced that an estimated 5 million children died beforecoronavirus_omicron_illustrationeir fifth birthday and…
On Jan. 10, 2023, the National Institutes of Health reported that antiviral treatments can help reduce the risk…
On Jan. 9, 2023, BD (Becton, Dickinson) and CerTest Biotec have announced Emergency Use Authorization (EUA) from the…
On Jan. 6, 2023, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway…
On Jan. 5, 2023, BioNTech announced that the Company had signed a Memorandum of Understanding with the Government…
On Jan. 5, 2023, the National Institutes of Health, in collaboration with the Administration for Strategic Preparedness and…
On Jan. 5, 2023, National Institutes of Health researchers announded they had published an assessment of 13 studies…
On Jan. 5, 2023, Novavax announced that Spain�s Public Health Commission, Italy�s Ministry of Health, and France�s Haute…
On Jan. 4, 2023, an international research group announced it had for the first time reconstructed ancestors dating…
On Jan. 4, 2023, a National Institutes of Health funded study reported that moderate levels of two outdoor…
Milestones in Polio illustrates the slow but steady advancements from its clinical description and discovery to widespread infection…
On Dec. 23, 2022, BioNTech and Fosun Pharmaceutical announced that they had received the certificates of registration as…
On Dec. 22, 2022, resarchers at the National Institutes of Health announced they had used patient stem cells…
On Dec. 21, 2022, the U.S. Department of Health and Human Services (HHS), through the Administration for Strategic…
On Dec. 21, 2022, Moderna announced the the finalization of a strategic partnership with the UK government to…
On Dec. 21, 2022, Roche announced that the U.S. Food and Drug Administration (FDA) had approved Actemraï¾® (tocilizumab)…
On Dec. 20, 2022, the University of Oxford announced study results using data from 7 million people notified…
On Nov. 12, 2022, the World Health Organization (WHO) issued a Disease Outbreak News (DON) on the circulating…
On Dec. 16, 2022, the U.S. Food and Drug Administration approved Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firadenovec-vncg), a non-replicating…
On Dec. 16, 2022, Novavax announced that the Standing Committee on Vaccination (STIKO) in Germany had expanded its…
On Dec. 16, 2022, Moderna announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use…
On Dec. 15, 2022, the University of Oxford Oxfordï¾’s Ebola vaccine candidate has been shipped to Uganda, just…
On Dec. 14, 2022, the National Institutes of Health announced that two randomized, placebo-controlled trials evaluating three Ebola…
On Dec. 13, 2022, Texas Biomed announced that it had been designated as a prime contractor by the…
On Dec. 11, 2022, Novavax announced that the Switzerland�s Federal Office of Public Health and France�s Haute Autorit�…
On Dec. 9, 2022, Washington University in St. Louis announced that it’s nasal COVID-19 vaccine technology had been…
On Dec. 9, 2022, the WHO announced that the first doses of one of the three candidate vaccines…
On Dec. 8, 2022, Moderna announced it had received emergency use authorization from the U.S. Food and Drug…